Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational ...

Traditional oncology care models have not effectively identified and managed at-risk patients to prevent acute care. A next step is to harness advances in technology to enable patients to report ...

Race Oncology Ltd. ( ($AU:RAC) ) just unveiled an update. Race Oncology has secured $3.22 million through a private placement ...

The Phase 1b, open-label, dose-escalation and dose-expansion trial evaluated LYT-200 both in combination with the standard-of-care (SOC) regimen of venetoclax (VEN) and a hypomethylating agent (HMA) ...

– Kura Oncology (KURA) will host a conference call on November 13, 2025, at 12:30 pm ET / 9:30 am PT – “KOMZIFTI combines compelling efficacy, a favorable safety profile, compatibility with ...

November 2025 saw pivotal FDA approvals, including durvalumab for gastric cancers and pembrolizumab/enfortumab vedotin for ...

An update from PureTech Health ( ($GB:PRTC) ) is now available. Gallop Oncology, a PureTech Health entity, announced promising results from a ...

A unique training programme for a new breed of cancer care doctors is underway at The Christie in Manchester, an international center of excellence in cancer care. Dr Richard Berman (left) welcomes Dr ...